Fast and accurate detection of swine influenza using Seegene’s Seeplex

Published: 2009-06-23 06:56:00

Updated: 2009-06-23 06:56:00

Seeegene, Inc., a local biotechnology company specialized in molecular diagnostics and research applications, said on June 12 that the Seoul National University Hospital confirmed additional patients with H1N1 influenza A using its “Seeplex," which sets a standard in high-throughput and simultane...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK